Dr. Gordon’s Comments: This 2.6 fold increase in heart disease in those who are wheezing suggests that my FIGHT program is needed for patients with heart disease issues.

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

Full article: http://www.nhiondemand.com/HSJArticle.aspx?id=914&utm_source=NHI+OnDemand+Newsletter+List&utm_campaign=a61eed16f7-HSJ_Sep30_2010&utm_medium=emai

Excerpt:

Allergy is a disorder of the immune system which is a form of hypersensitivity. An allergic reaction is an inappropriate immune reaction to an otherwise harmless substance. Allergens can be environmental, chemical, or food-based. Common allergens include dust mites, pollen, animal dander, and certain foods. Allergens can be absorbed into the body through the skin, respiratory tract, or gastrointestinal tract. Allergens are proteins or low-molecular weight substances that the body identifies as antigenic. This creates an immune response known as a hypersensitive or allergic reaction. The production of chemical mediators in these allergic reactions may produce symptoms ranging from mild to life threatening.

In the United States, the most common type of heart disease and the leading cause of death is coronary heart disease also known as coronary artery disease (CAD). Coronary artery disease occurs when a substance called plaque builds up in the arteries that supply blood to the heart (called coronary arteries). Plaque is made up of cholesterol deposits, which can accumulate in your arteries. When this happens, your arteries can narrow over time. This process is called atherosclerosis. Plaque buildup can cause angina, the most common symptom of CAD. This condition causes chest pain or discomfort because the heart muscle doesn’t get enough blood. Over time, CAD can weaken the heart muscle. This may lead to heart failure, a serious condition where the heart can’t pump blood the way that it should. An irregular heartbeat, or arrhythmia, can also develop. For some people, the first sign of CAD is a heart attack. A heart attack occurs when plaque totally blocks an artery carrying blood to the heart. It also can happen if a plaque deposit breaks off and clots a coronary artery. 

  Lethal and toxic levels of hydrogen sulfide, benzene, and methalene chloride are floating in the air over the oil spill. There’s a very high probability that residents exposed to the air surrounding the spill will suffer a direct hit to their health status such as debilitating diseases or various birth deformities and cancer as a long-term result. But first what these people will see is flu-like symptoms, which, like in the flu, are symptoms of intolerable amounts of foreign toxins, chemicals and heavy metals in the tissues dumping into the bloodstream.
 
     Even a small amount of benzene exposure can cause temporary nervous system disorders, immune system depression and anemia. Short-term affects include skin, eye, and respiratory tract irritation, headache, stomach irritation, drowsiness and dizziness. High levels of exposure can result in a rapid heart rate, excessive bleeding, tremors, vomiting, unconsciousness and death. Benzene can cause harmful effects on bone marrow and a decrease in red blood cells leading to myelofibrosis and myelodysplastic syndrome.
 
     That’s how it starts. Chemical exposure symptoms feel like a flu. Professor I.M. Trakhtenberg of Russia gives us a big hint when he says, “Chronic mercury exposure is also a threat to our health and makes us especially vulnerable to flu infections. It has been shown that “prolongedexposure of mammals (white mice) to low mercury concentrations (0.008 – 0.02mg/m3) leads to a significant increase in the susceptibility of mice topathological influenza virus strains.” For contemporary medicine to respond in an appropriate and humane way to the oil disaster it will have to leap out of the quagmire of its present paradigm an into one that understands the ‘terrain’ of human physiology and how that terrain is being overrun by chemical toxicity and heavy metals. WE DO NOT NEED TO BE ATTACKED BY AN INFLUENZA VIRUS STRAIN TO GET THE FLU. When we are attacked with nasty chemicals we are as likely to get the flu as when we are run over by viruses, which are more potent at driving health officials mad as at causing pandemics.
 
     “Blood elements such as WBCs, RBCs, hemoglobin, and bone marrow are adversely affected. With tissue proteins there is alteration of biological properties and protein synthesis. Enzyme; hormone; and endocrine functions of pituitary, adrenal, thyroid, ovaries, and testes are altered. There are pathological effects on the heart, liver, immune system, central nervous system, lungs, kidneys, and spleen.” continues Dr. Trakhtenberg.
 
     Thiol poisons react with SH groups of proteins, which leads to lowering the activity of various enzymes containing these proteins. This produces a series of disruptionsin the functional activity of many organs and tissues and this is the mechanism and pathological pathway of poisons that run us right into the ground. A toxic storm is gathering in the Gulf of Mexico and it contains devastating chemicals that can and will poison and destroy proteins with sulfur bonds.
 
Associated Illnesses
 
     According to the U.S. Department of Veterans Affairs, between 175,000 and 210,000 – or about 25 percent – of the living veterans of the 1991 Gulf War are currently afflicted by a debilitating, chronic, multi-symptom, multi-system disease commonly known as Gulf War Illness or Gulf War Syndrome. The Environmental Illness Resource , (http://imva.us1.list-manage.com/track/click?u=25b08cc8b5ebaf472984d04d0&id=f7a015aaa4&e=a053e43583) tells us that more than 110,000 cases had been reported by 1999, according to official government sources. There is even a report relating to military personnel in Kansas developing flu-like symptoms and chemical sensitivities after handling archived documents returned from the Gulf. In the UK, veterans of the 2003 conflict began reporting symptoms identical to those reported by the first war shortly after they returned from duty.
 
     The symptoms reported by veterans include:
 
Fatigue
Persistent Headaches
Muscle Aches/Pains
Neurological Symptoms, e.g. tingling and numbness in limbs
Cognitive Dysfunction – short-term memory loss, poor concentration, inability to take in information
Mood and Sleep Disturbances – Depression, Anxiety, Insomnia
Dermatological Symptoms – Skin Rashes, Unusual Hair Loss
Respiratory Symptoms – Persistent Coughing, Bronchitis, Asthma
Chemical Sensitivities
Gastrointestinal Symptoms – Diarrhea, Constipation, Nausea, Bloating
Cardiovascular Symptoms
Menstrual Symptoms
 
     These symptoms are similar to those attributed to chronic fatigue syndrome, multiple chemical sensitivities and other environmental illnesses. This similarity hasn’t gone unnoticed, which is why many people, including healthcare professionals and researchers, are coming to the conclusion that all these illnesses share common causes and etiologies. Gulf War vets have developed ALS, or Lou Gehrig’s disease, at twice the rate of vets who did not serve in the Gulf War. Some veterans returned seemingly well, yet developed severe illnesses months or years later. The lag time between cause and effect makes understanding these illnesses more difficult.
 
     Coalition troops were constantly exposed to chemicals (and vaccines) whose use is considered safe by people and organizations that do not know a safe substance from a dangerous one. The retreating Iraqi army ignited approximately 600 oil wells in February 1991, which burned for about nine months. These fires produced massive amounts of thick smoke that sometimes drifted to ground level causing increased exposure to ground troops. When this occurred the air pollution was far greater than would be experienced in the average traffic congested western city.
 
     Questionnaires filled in by US troops indicated higher rates of eye and upper respiratory tract irritation, shortness of breath, cough, rashes, and fatigue than unexposed troops. The smoke from oil well fires contained a cocktail of chemicals, notably benzene, hydrogen sulfide and sulfur dioxide as well as quantities of particulate matter.
 
Read The Full Article
Mark Sircus Ac., OMD
Director International Medical Veritas Association
http://publications.imva.info
http://blog.imva.info
 

Silver has been known for its medicinal and antimicrobial properties for thousands of years. Hippocrates, “Father of Medicine,” used silver for tissue repair & wound healing. In 69 B.C. silver nitrate was described in the contemporary pharmacopoeia. The ancient civilizations of Greece and Rome used silver to control bodily infection & prevent food spoilage. The King of Persia used silver containers to carry water to prevent contamination. Throughout the ages, the ‘Metal of the Moon’ as it was known to some of the ancients has been used effectively for numerous medicinal purposes.

Beyond prescribing any silver-based product for its antimicrobial effect, it is necessary in successful practice to distinguish the vast differences in performance amongst competing brands. Clearly silver is not just silver. Major formulation advancements have been made in the last 150 years since the first electrolytically produced colloidal silvers came into existence. To understand the difference in antimicrobial activity between the leading evidence based silver products currently available, we need only compare kill kinetics studies against various benchmark microorganisms.

The most effective antimicrobials within the clinical setting are defined as broad-spectrum; exhibiting bactericidal, virucidal, fungicidal and more in killing effect. As there are a near infinite number of types, and genetic variations of pathogens, antimicrobial research is best accomplished by Association of Analytical Communities (AOAC) standard, invitro kill time studies. This is the same protocol utilized by the Environmental Protection Agency (EPA) in determining the germicidal efficiency of a pesticide/disinfectant. The AOAC protocols are accepted and recognized as standard.

In my investigations, I have compiled kill kinetics data of three of the better known silver-based antimicrobial products currently on the market, which I obtained from the manufacturer’s own websites. Included in this comparative analysis are the independently derived, and independently published kill kinetics test results of Results RNA Advanced Cellular Silver (ACS) 200®, American Biotech ASAP silver® and Purest Colloids, Inc. MesoSilver® against three benchmark microorganisms; Methicillin‐resistant Staphylococcus aureus (MRSA), Candida albicans, and Staphylococcus aureus.

Before we examine the data, a simple defining of terms is necessary:

Titer: Synonymous with Microbe Concentration. Titer refers to the number of organisms calculated in the culture prior to testing.
Log Reduction: Defines the percentage of kill in logarithms.
Methicillin‐resistant Staphylococcus aureus (MRSA) – Comparative Kill Time Study
MRSA  Titer  Log Reduction  Time 
ACS 200*  2,170,000,000  6.64/99.999984%  < 3 minutes 
ASAP silver  1,900,000  4.98/99.9989%  60 minutes 
Meso Silver  1,200,000  Log not provided claimed kill 5 hours
* Performed using AOAC methods
ACS 200 titer is 114,210% greater than ASAP silver titer
ACS 200 titer is 180,833% greater than MesoSilver titer
www.aoac.org – Association of Analytical Communities

ACS 200® (tested by AOAC) provides a >6.64 log reduction/99.999984% complete kill in less than 3 minutes.
ASAP® silver provides a >4.98 log reduction/99.9989% complete kill in 60 minutes.
MesoSilver® requires 300 minutes to achieve complete kill against MRSA. (Actual Log reduction not provided in published report.)
Microbe Concentrations: The initial microbe concentration (titer) of MRSA used with ACS 200® for testing is significantly larger than the titers used by ASAP® silver and MesoSilver®. Comparisons are as follows:
MRSA Microbe Concentrations by Product

ACS 200® MRSA titer: 2.17 X 109
ASAP® silver MRSA titer: 1.9 x 106
MesoSilver® MRSA titer: 1.2 x 106

MRSA Microbe Concentrations Compared

The 2.17 X 109 ACS 200® titer is 1,142 times larger than the 1.9 x 106 ASAP® silver titer.
The 2.17 X 109 ACS 200 titer is 1,808 times larger than the 1.2 x 106 MesoSilver® titer.

MRSA Testing Conclusion:

ACS 200® achieves complete kill (without a single organism left alive) against 2,170,000,000 MRSA organisms in less than 3 minutes.
ACS 200® achieves a significant 20 times faster kill than ASAP® silver against Methicillin‐resistant Staphylococcus aureus evidencing a 3 minute/99.999984% >6.64 log reduction versus a 60 minute/99.9989% >4.98 log reduction, while killing an 1,142 times greater number of MRSA organisms.
ACS 200® achieves ­­a significant 100 times faster kill than MesoSilver® against Methicillin‐resistant Staphylococcus aureus evidencing a 3 minute/99.999984% >6.64 log reduction versus a 300 minute kill time, while killing an 1,808 times greater number of MRSA organisms.

Candida albicans – Comparative Kill Time Study
C. albicans Titer  Log Reduction  Time 
ACS 200*  445,000,000  5.95/99.99989%  2 minutes 
ASAP silver  1,300,000  4.83/99.9985%  60 minutes 
Meso Silver  12,000 Log not provided claimed kill 24 hours
* Performed using AOAC methods
ACS 200 titer is 34,230% greater than ASAP silver titer
ACS 200 titer is 370,833% greater than MesoSilver titer

ACS 200® provides a >5.95 log reduction/99.99989% kill in 2 minutes.
ASAP® silver provides a >4.83 log reduction/99.9985% kill in 60 minutes.
MesoSilver® requires 1,440 minutes to achieve complete kill. (Actual Log reduction not provided in published report.)
Microbe Concentrations: The initial microbe concentration (titer) of Candida albicans used with ACS 200® for testing is significantly larger than the titers used by ASAP® silver and MesoSilver®. Comparisons are as follows:
Candida albicans Microbe Concentrations by Product

ACS 200® Candida titer: 4.45 x 108
ASAP® silver Candida titer: 1.3 x 106
MesoSilver® Candida titer: 1.2 x 104

Candida Microbe Concentrations Compared

The 4.45 x 108 Candida titer (ACS 200®) is 342 times larger than the 1.3 x 106 Candida titer (ASAP® silver).
The 4.45 x 108 Candida titer (ACS 200®) is 37,083 times larger than the 1.2 x 104 Candida titer (MesoSilver®).

Candida Testing Conclusion

ACS 200® achieves complete kill (without a single organism left alive) against 445,000,000 Candida organisms in less than 3 minutes.
ACS 200® achieves a significant 30 times faster kill than ASAP® silver against Candida albicans evidencing a 2 minute/99.99989% >5.95 log reduction versus a 60 minute/99.9985% >4.83 log reduction, while killing a 342 times greater number of Candida organisms.
ACS 200® achieves ­­a significant 720 times faster kill than MesoSilver® against Candida albicans evidencing a 2 minute/99.99989% >5.95 log reduction versus a 1,440 minute kill time, while killing a 37,083 times greater number of Candida organisms.
Staphylococcus aureus – Comparative Kill Time Study
S. aureus Titer  Log Reduction  Time 
ACS 200*  234,000,000  > 5.37/99.9996%  15 seconds 
ASAP silver  2,300,000 > 5.06/99.99914%  60 minutes 
Meso Silver  830,000 Log not provided claimed kill 24 hours
* Performed using AOAC methods
ACS 200 titer is 10,173% greater than ASAP silver titer
ACS 200 titer is 28,192% greater than MesoSilver titer
ACS 200® provides a >5.37 log reduction/99.9996% kill in 15 seconds.
ASAP® silver provides a >5.06 log reduction/99.99914% kill in 60 minutes.
MesoSilver® requires 1,440 minutes to achieve complete kill. (Actual Log reduction not provided in published report.)
Microbe Concentrations: The initial microbe concentration (titer) of Staphylococcus aureus used with ACS 200® for testing is significantly larger than the titers used by ASAP® silver and MesoSilver®. Comparisons are as follows:
Staphylococcus aureus Microbe Concentrations by Product

ACS 200® S. aureus titer: 2.34 x 108
ASAP® silver S. aureus titer: 2.3 x 106
MesoSilver® S. aureus titer: 8.3 x 105

Microbe Concentrations Compared

The 2.34 x 108 ACS 200® titer is 101 times larger than the 2.3 x 106 ASAP silver titer.
The 2.34 x 108 ACS 200 titer is 281 times larger than the 8.3 x 105 MesoSilver® titer.

Staph Aureus Testing Conclusion:

ACS 200® achieves complete kill (without a single organism left alive) against 234,000,000 S. aureus organisms in less than 15 seconds.
ACS 200® achieves a significant 240 times faster kill than ASAP® silver against S. aureus evidencing a 15 second/99.9996% >5.06 log reduction versus a 60 minute/99.99914% >5.06 log reduction, while killing 101 times greater number of S. aureus organisms.
ACS 200® achieves ­­a significant 5,760 times faster kill than MesoSilver® against S. aureus evidencing a 15 second/99.9996% >5.06 log reduction versus a 1,440 minute kill time, while killing a 281 times greater number of S. aureus organisms.
Conclusion
As you can see, the performance of these three silver formulations differs greatly. ACS 200® achieves 100’s of times faster kill in just minutes, against thousands of times greater number of pathogenic microorganisms.

With enhanced killing effect, superior efficacy and patient outcomes are readily discernable with ACS 200® versus competing antimicrobial products. In our clinical experience over the last several years, many practitioners have seen ACS 200® perform extremely well against a host of pathogenic microorganisms, with high benefit and very little risk.
——————————————————————————–
Download Original Kill Time Studies Here
 ACS 200 vs MRSA
 ACS 200 vs Candida albicans
 ACS 200 vs Staph aureus

 ASAP Silver vs MRSA
 ASAP Silver vs Candida albicans
 ASAP Silver vs Staph aureus

 Meso Silver vs MRSA
 Meso Silver vs Candida albicans
 Meso Silver vs Staph aureus

 
——————————————————————————–
 
 
 
Copyright © 2009 Results RNA, LLC All rights reserved.
For more information visit our website at www.resultsrna.com